Patents by Inventor Jeffrey FERNANDEZ

Jeffrey FERNANDEZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYSTEMS AND METHODS FOR DRYING REAGENTS IN MULTIWELL PLATES
    Publication number: 20240157367
    Abstract: Disclosed herein is a device for multianalyte detection, and systems and methods for drying reagents in wells in the device in a manner that preserves functional performance. Specifically, disclosed is a system for drying reagents in the wells of a multiwell plate. The multiwell plate is sprayed with air from nozzles positioned above the multiwell plate. Air is exhausted evenly below the multiwell plate. This allows for the rapid, consistent drying of large volumes of liquid in the well of a multiwell plate.
    Type: Application
    Filed: November 10, 2023
    Publication date: May 16, 2024
    Applicant: Truvian Sciences, Inc.
    Inventors: Jeffrey A. Hawkins, Mark Scheble, Mohammad Sotoudeh, Brian Fernandez
  • VISUALIZATION OF CHANGES THROUGH THE USE OF GRAPHICAL GEOMETRIC SHAPES
    Publication number: 20240144366
    Abstract: Methods and systems are disclosed for determining changes or revisions to a set of data and providing a user with a computerized graphical depiction of these changes through the use of multiple geometric shapes, the positioning of which shapes relative to one another and the size of which shapes relative to one another depict the changes to the user.
    Type: Application
    Filed: January 10, 2024
    Publication date: May 2, 2024
    Inventors: Todd Berlent, Jeffrey Stephens, Luis Fernandez
  • TIRZEPATIDE THERAPEUTIC METHODS
    Publication number: 20240100127
    Abstract: An embodiment of the invention relates to method for increasing HDL-C in a patient in need thereof. An embodiment of the invention relates to a method for decreasing high blood pressure. An embodiment relates to a treatment method for a patient with refractory type 2 diabetes to provide normal HbA1C glycemia.
    Type: Application
    Filed: February 2, 2022
    Publication date: March 28, 2024
    Inventors: Mathijs Christiaan Michael BUNCK, Laura FERNANDEZ LANDO, Jeffrey Scott RIESMEYER, Angel RODRIGUEZ BERNARDINO
  • STAPHYLOCOCCUS PEPTIDES AND METHODS OF USE
    Publication number: 20220362368
    Abstract: Provided herein are immunogenic compositions comprising a Staphylococcus aureus protein A (SpA) variant and a mutant staphylococcal leukocidin subunit polypeptide comprising a LukA polypeptide, a LukB polypeptide, and/or a LukAB dimer polypeptide, wherein the LukA polypeptide, the LukB polypeptide, and/or the LukAB dimer polypeptide have one or more amino acid substitutions, deletions, or a combination thereof.
    Type: Application
    Filed: October 2, 2020
    Publication date: November 17, 2022
    Inventors: Jan Theunis POOLMAN, Olaf SCHNEEWIND, Dominique MISSIAKAS, Yan SUN, Hwan Keun KIM, Miaomiao SHI, Xinhai CHEN, Jeffrey A. FERNANDEZ
  • Compositions and methods for anti-staphylococcal biologic agents
    Patent number: 10781246
    Abstract: The present disclosure is directed to staphylococcal leukotoxin and hemolysin binding molecules and fusion constructs. The present disclosure is further directed to methods of treating, preventing, and diagnosing staphylococcal infection in a subject using the binding molecules and fusion constructs described herein.
    Type: Grant
    Filed: June 4, 2016
    Date of Patent: September 22, 2020
    Assignees: NEW YORK UNIVERSITY, JANSSEN BIOTECH, INC.
    Inventors: Randall J. Brezski, Anthony S. Lynch, Peter T. Buckley, Jeffrey Fernandez, Jinquan Luo, Thomas J. Malia, Sheng-Jiun Wu, Victor J. Torres
  • COMPOSITIONS AND METHODS FOR ANTI-STAPHYLOCOCCAL BIOLOGIC AGENTS
    Publication number: 20190127444
    Abstract: The present disclosure is directed to staphylococcal leukotoxin and hemolysin binding molecules and fusion constructs. The present disclosure is further directed to methods of treating, preventing, and diagnosing staphylococcal infection in a subject using the binding molecules and fusion constructs described herein.
    Type: Application
    Filed: June 4, 2016
    Publication date: May 2, 2019
    Inventors: Randall J. BREZSKI, Anthony S. LYNCH, Peter T. BUCKLEY, Jeffrey FERNANDEZ, Jinquan LUO, Thomas J. MALIA, Sheng-Jiun WU, Victor J. TORRES